Form 8-K - Current report:
SEC Accession No. 0000200406-21-000061
Filing Date
2021-08-20
Accepted
2021-08-20 16:31:14
Documents
14
Period of Report
2021-08-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20210819.htm   iXBRL 8-K 52379
2 EX-99.1 exhibit99.htm EX-99.1 26724
  Complete submission text file 0000200406-21-000061.txt   298926

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20210819.xsd EX-101.SCH 3542
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20210819_def.xml EX-101.DEF 17377
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20210819_lab.xml EX-101.LAB 35650
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20210819_pre.xml EX-101.PRE 18240
7 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20210819_htm.xml XML 20915
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0102
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 211194241
SIC: 2834 Pharmaceutical Preparations